Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

Watson and reverse payments: an opportunity to resolve the competing tension between antitrust and patent law under the Hatch-Waxman Act

Proskauer Rose LLP
-
USA
-
March 8 2013

On March 25, the Supreme Court will hear arguments in Federal Trade Commission v. Watson Pharmaceuticals, Inc., and take a step toward concluding

Placing limits on the State Action Doctrine, the Supreme Court subjects local government hospitals to scrutiny under the antitrust laws

Proskauer Rose LLP
-
USA
-
February 21 2013

Recent major regulatory and technological developments have brought forth historic changes to the health care market. Health care providers have

FTC sights set on pharma deals calls for additional Hart-Scott-Rodino reporting

Proskauer Rose LLP
-
USA
-
August 28 2012

The Federal Trade Commission has proposed expanding Hart-Scott-Rodino reporting and waiting period obligations for certain pharmaceutical, biologics and medicine manufacturing licenses

Third Circuit creates reverse payments split among the circuits

Proskauer Rose LLP
-
USA
-
July 25 2012

Rejecting the test established by three separate courts of appeal, the Third Circuit's recent decision in In re K-Dur Antitrust Litigation has created a circuit split regarding the legality of, and application of antitrust law to, "pay-for-delay" settlements to patent lawsuits

Phoebe Putney - the Supreme Court grants certiorari to determine the boundaries of state action antitrust immunity

Proskauer Rose LLP
-
USA
-
July 2 2012

On June 25, 2012, the U.S. Supreme Court granted the Federal Trade Commission's request to hear arguments in FTC v. Phoebe Putney Health System, Inc., a highly anticipated hospital merger case which likely will clarify the circumstances in which state regulation can create immunity from federal antitrust law

FTC's renewed focus on hospital merger enforcement reflected in appointment of its first deputy director for health care and antitrust

Proskauer Rose LLP
-
USA
-
June 27 2012

This note briefly analyzes the scholarly work of Leemore Dafny, who recently has been appointed as the FTC's first Deputy Director for Health Care and Antitrust, beginning August 1

How antitrust affects your health: the antitrust laws' impact on the delivery of healthcare services in America

Proskauer Rose LLP
-
USA
-
March 26 2012

The healthcare industry is undergoing a massive restructuring, driven by fundamental shifts in the economy

Search results

Watson and reverse payments: an opportunity to resolve the competing tension between antitrust and patent law under the Hatch-Waxman Act

Placing limits on the State Action Doctrine, the Supreme Court subjects local government hospitals to scrutiny under the antitrust laws

FTC sights set on pharma deals calls for additional Hart-Scott-Rodino reporting

Third Circuit creates reverse payments split among the circuits

Phoebe Putney - the Supreme Court grants certiorari to determine the boundaries of state action antitrust immunity

FTC's renewed focus on hospital merger enforcement reflected in appointment of its first deputy director for health care and antitrust

How antitrust affects your health: the antitrust laws' impact on the delivery of healthcare services in America

Current Search

Suggested Facets

Author

Workarea